A clustering approach to identify severe bronchiolitis profiles in children

Thorax

Volumn 71, Issue 8, 2016, Pages 712-718

  Dumas, Orianne ^a,b,c,d   Mansbach, Jonathan M ^b,e   Jartti, Tuomas ^f   Hasegawa, Kohei ^a,b   Sullivan, Ashley F ^a   Piedra, Pedro A ^g   Camargo, Carlos A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSERM   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BRONCHIOLITIS; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECZEMA; EMERGENCY WARD; FEMALE; FEVER; FINLAND; HOSPITAL ADMISSION; HOSPITALIZED CHILD; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINOVIRUS INFECTION; RISK FACTOR; SEASONAL VARIATION; UNITED STATES; VIRUS ETIOLOGY; WHEEZING; BRONCHIOLITIS, VIRAL; CLINICAL TRIAL; CLUSTER ANALYSIS; COMPLICATION; HOSPITAL; PRESCHOOL CHILD; RESPIRATORY SOUNDS; VIROLOGY;

BRONCHIOLITIS; BRONCHIOLITIS, VIRAL; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COHORT STUDIES; ECZEMA; FEMALE; FINLAND; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; UNITED STATES;

EID: 84977533970     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208535     Document Type: Article

References (37)

1. Carroll KN, Gebretsadik T, Griffin MR, et al. Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics 2008;122:58-64.
2. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014;134: e1474-502.
3. Vicencio AG. Susceptibility to bronchiolitis in infants. Curr Opin Pediatr 2010;22:302-6.
4. Hasegawa K, Mansbach JM, Teach SJ, et al. Multicenter study of viral etiology and relapse in hospitalized children with bronchiolitis. Pediatr Infect Dis J 2014;33:809-13.
5. Jartti T, Lehtinen P, Vuorinen T, et al. Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J 2009;28:311-17.
6. Vinci R, Bauchner H. Bronchiolitis, deception in research, and clinical decision making. JAMA 2014;312:699-700.
7. Mansbach JM, Piedra PA, Teach SJ, et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 2012;166:700-6.
8. Jartti T, Aakula M, Mansbach JM, et al. Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis. Pediatr Infect Dis J 2014;33:829-34.
9. Skjerven HO, Megremis S, Papadopoulos NG, et al. Virus type and genomic load in acute bronchiolitis: severity and treatment response with inhaled adrenaline. J Infect Dis 2016;213:915-21.
10. Mansbach JM, Clark S, Piedra PA, et al. Hospital course and discharge criteria for children hospitalized with bronchiolitis. J Hosp Med 2015;10:205-11.
11. Rossi GA, Colin AA. Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing. Eur Respir J 2015;45:774-89.
12. Feldman AS, He Y, Moore ML, et al. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med 2015;191:34-44.
13. Fuchs O, von Mutius E. Prenatal and childhood infections: Implications for the development and treatment of childhood asthma. Lancet Respir Med 2013;1:743-52.
14. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008;178:667-72.
15. Thomsen SF, van der Sluis S, Stensballe LG, et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 2009;179:1091-7.
16. Bacharier LB, Cohen R, Schweiger T, et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2012;130:91-100.
17. Carroll KN, Wu P, Gebretsadik T, et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol 2009;123:1055-61.
18. Siroux V, Garcia-Aymerich J. The investigation of asthma phenotypes. Curr Opin Allergy Clin Immunol 2011;11:393-9.
19. Vanfleteren LEGW, Kocks JWH, Stone IS, et al. Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax 2014;69:72-9.
20. Depner M, Fuchs O, Genuneit J, et al. Clinical and epidemiologic phenotypes of childhood asthma. Am J Respir Crit Care Med 2014;189:129-38.
21. Henderson J, Granell R, Heron J, et al. Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood. Thorax 2008;63:974-80.
22. Schroeder AR, Mansbach JM. Recent evidence on the management of bronchiolitis. Curr Opin Pediatr 2014;26:328-33.
23. Jartti T, Nieminen R, Vuorinen T, et al. Short-And long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode. J Allergy Clin Immunol 2015;135:691-8.
24. Zorc JJ. Inhaled epinephrine does not shorten hospital stay for infants with bronchiolitis destined to develop repeated bronchospasm. Lancet Respir Med 2015;3:665-7.
25. Mazur NI, Martinón-Torres F, Baraldi E, et al. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med 2015;3:888-900.
26. Skjerven HO, Rolfsjord LB, Berents TL, et al. Allergic diseases and the effect of inhaled epinephrine in children with acute bronchiolitis: Follow-up from the randomised, controlled, double-blind, Bronchiolitis ALL trial. Lancet Respir Med 2015;3:702-8.
27. Herr M, Just J, Nikasinovic L, et al. Risk factors and characteristics of respiratory and allergic phenotypes in early childhood. J Allergy Clin Immunol 2012;130:389-96.
28. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774-93.
29. Siroux V, Basagaña X, Boudier A, et al. Identifying adult asthma phenotypes using a clustering approach. Eur Respir J 2011;38:310-17.
30. Hyvärinen M, Ruotsalainen M, Korppi M. Outcome after bronchiolitis depends on disease definition. Thorax 2011;66:266-7; author reply 267.
31. Mattes J, Murphy VE, Powell H, et al. Prenatal origins of bronchiolitis: protective effect of optimised asthma management during pregnancy. Thorax 2014;69:383-4.
32. Carroll KN, Gebretsadik T, Minton P, et al. Influence of maternal asthma on the cause and severity of infant acute respiratory tract infections. J Allergy Clin Immunol 2012;129:1236-42.
33. Jackson DJ, Evans MD, Gangnon RE, et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012;185:281-5.
34. Caliskan M, Bochkov YA, Kreiner-Møller E, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013;368:1398-407.
35. Alansari K, Sakran M, Davidson BL, et al. Oral dexamethasone for bronchiolitis: a randomized trial. Pediatrics 2013;132:e810-16.
36. DeLaMora P, Moscona A. Bronchiolitis: too-familiar yet too-mysterious disease of childhood. Arch Pediatr Adolesc Med 2012;166:769-70.
37. Belgrave D, Simpson A, Custovic A. Challenges in interpreting wheeze phenotypes: the clinical implications of statistical learning techniques. Am J Respir Crit Care Med 2014;189:121-2.